Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,169.46
(
0.47%
)
US TECH 100
26,523.92
(
0.23%
)
Dow Jones
49,559.00
(
1.43%
)
Brent Oil
109.50
(
-2.56%
)
Bitcoin
76,352.95
(
0.76%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: volgoat post# 249473

Sunday, 01/17/2016 7:00:13 PM

Sunday, January 17, 2016 7:00:13 PM

Post# of 347009
Peregrine Pharmaceuticals has the support of key alliances and maybe you should keep an eye on the modulations at the cellular level being talked about at ITOC3 in Germany. Sunrise late breaking abstract to pop up there ..... : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote